A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis

Clinical trial NCT01712399 · TERMINATED

Trial details

NCT number: NCT01712399
Sponsor: MedImmune LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2013-01-28
Primary completion: 2015-12-30
Enrollment: 409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.